Improved effectiveness of generic medicine markets in Hungary. Analysis and recommendations (2015)

2015
This publication summarizes the findings of a series of technical reports by many experts involved in assessing the effectiveness of pharmaceutical policy on generic essential medicines markets in the context of the Hungarian health system. Within the framework of certain agreements, WHO provided technical advice in collaboration with local experts and with involvement from international consultants.
The primary objective of this report is to provide an overview of the development of incentives to use generics in the Hungarian health system up to the end of 2011, focusing in particular on the reference pricing system and assessing what impact these incentives have had in recent years.